Phase 1 trial of avelumab (anti-PD-L1) in Japanese patients with advanced solid tumors, including dose expansion in patients with gastric or gastroesophageal junction cancer: the JAVELIN Solid Tumor JPN trial
Doi, Toshihiko, Iwasa, Satoru, Muro, Kei, Satoh, Taroh, Hironaka, Shuichi, Esaki, Taito, Nishina, Tomohiro, Hara, Hiroki, Machida, Nozomu, Komatsu, Yoshito, Shimada, Yasuhiro, Otsu, Satoshi, Shimizu, Shin, Watanabe, Morihiro
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.07.2019)
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.07.2019)
Get full text
Journal Article
Efficacy of second-line chemotherapy after treatment with gemcitabine plus nab-paclitaxel or FOLFIRINOX in patients with metastatic pancreatic cancer
Fukahori, Masaru, Okabe, Yoshinobu, Shimokawa, Mototsugu, Otsuka, Taiga, Koga, Futa, Ueda, Yujiro, Nakazawa, Junichi, Komori, Azusa, Otsu, Satoshi, Arima, Shiho, Makiyama, Akitaka, Taguchi, Hiroki, Honda, Takuya, Ushijima, Tomoyuki, Miwa, Keisuke, Shibuki, Taro, Nio, Kenta, Ide, Yasushi, Ureshino, Norio, Mizuta, Toshihiko, Mitsugi, Kenji, Shirakawa, Tsuyoshi
Published in Scientific reports (08.11.2023)
Published in Scientific reports (08.11.2023)
Get full text
Journal Article
A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study
Otsuka, Taiga, Shirakawa, Tsuyoshi, Shimokawa, Mototsugu, Koga, Futa, Kawaguchi, Yasunori, Ueda, Yujiro, Nakazawa, Junichi, Komori, Azusa, Otsu, Satoshi, Arima, Shiho, Fukahori, Masaru, Okabe, Yoshinobu, Makiyama, Akitaka, Taguchi, Hiroki, Honda, Takuya, Shibuki, Taro, Nio, Kenta, Ide, Yasushi, Mizuta, Toshihiko, Mitsugi, Kenji, Ureshino, Norio
Published in International journal of clinical oncology (01.05.2021)
Published in International journal of clinical oncology (01.05.2021)
Get full text
Journal Article
C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel
Shirakawa, Tsuyoshi, Makiyama, Akitaka, Shimokawa, Mototsugu, Otsuka, Taiga, Shinohara, Yudai, Koga, Futa, Ueda, Yujiro, Nakazawa, Junichi, Otsu, Satoshi, Komori, Azusa, Arima, Shiho, Fukahori, Masaru, Taguchi, Hiroki, Honda, Takuya, Shibuki, Taro, Nio, Kenta, Ide, Yasushi, Ureshino, Norio, Mizuta, Toshihiko, Mitsugi, Kenji, Akashi, Koichi, Baba, Eishi
Published in Scientific reports (31.05.2023)
Published in Scientific reports (31.05.2023)
Get full text
Journal Article
Author Correction: C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel
Shirakawa, Tsuyoshi, Makiyama, Akitaka, Shimokawa, Mototsugu, Otsuka, Taiga, Shinohara, Yudai, Koga, Futa, Ueda, Yujiro, Nakazawa, Junichi, Otsu, Satoshi, Komori, Azusa, Arima, Shiho, Fukahori, Masaru, Taguchi, Hiroki, Honda, Takuya, Shibuki, Taro, Nio, Kenta, Ide, Yasushi, Ureshino, Norio, Mizuta, Toshihiko, Mitsugi, Kenji, Akashi, Koichi, Baba, Eishi
Published in Scientific reports (04.03.2024)
Published in Scientific reports (04.03.2024)
Get full text
Journal Article
Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab-paclitaxel or FOLFIRINOX: A post-hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study)
Shibuki, Taro, Mizuta, Toshihiko, Shimokawa, Mototsugu, Koga, Futa, Ueda, Yujiro, Nakazawa, Junichi, Komori, Azusa, Otsu, Satoshi, Arima, Shiho, Fukahori, Masaru, Makiyama, Akitaka, Taguchi, Hiroki, Honda, Takuya, Mitsugi, Kenji, Nio, Kenta, Ide, Yasushi, Ureshino, Norio, Shirakawa, Tsuyoshi, Otsuka, Taiga
Published in BMC cancer (03.01.2022)
Published in BMC cancer (03.01.2022)
Get full text
Journal Article
A multicentre retrospective study comparing site-specific treatment with empiric treatment for unfavourable subset of cancer of unknown primary site
Nishikawa, Kazuo, Hironaka, Shuichi, Inagaki, Takashi, Komori, Azusa, Otsu, Satoshi, Mitsugi, Kenji, Makiyama, Akitaka, Watanabe, Koichiro, Tamura, Shingo, Okumura, Yuta, Kusaba, Hitoshi, Esaki, Taito, Baba, Eishi, Shirao, Kuniaki
Published in Japanese journal of clinical oncology (05.12.2022)
Published in Japanese journal of clinical oncology (05.12.2022)
Get full text
Journal Article
Nanoliposomal irinotecan with fluorouracil and folinic acid, FOLFIRINOX, and S-1 as second-line treatment for unresectable pancreatic cancer after gemcitabine/nab-paclitaxel
Shibuki, Taro, Otsuka, Taiga, Shimokawa, Mototsugu, Nakazawa, Junichi, Arima, Shiho, Fukahori, Masaru, Miwa, Keisuke, Okabe, Yoshinobu, Koga, Futa, Ueda, Yujiro, Kubotsu, Yoshihito, Makiyama, Akitaka, Shimokawa, Hozumi, Takeshita, Shigeyuki, Nishikawa, Kazuo, Komori, Azusa, Otsu, Satoshi, Hosokawa, Ayumu, Sakai, Tatsunori, Oda, Hisanobu, Kawahira, Machiko, Arita, Shuji, Honda, Takuya, Taguchi, Hiroki, Tsuneyoshi, Kengo, Kawaguchi, Yasunori, Fujita, Toshihiro, Sakae, Takahiro, Nio, Kenta, Ide, Yasushi, Ureshino, Norio, Shirakawa, Tsuyoshi, Mizuta, Toshihiko, Mitsugi, Kenji
Published in Scientific reports (23.07.2024)
Published in Scientific reports (23.07.2024)
Get full text
Journal Article
Phase II trial of aflibercept with FOLFIRI as a second‐line treatment for Japanese patients with metastatic colorectal cancer
Denda, Tadamichi, Sakai, Daisuke, Hamaguchi, Tetsuya, Sugimoto, Naotoshi, Ura, Takashi, Yamazaki, Kentaro, Fujii, Hirofumi, Kajiwara, Takeshi, Nakajima, Takako Eguchi, Takahashi, Shin, Otsu, Satoshi, Komatsu, Yoshito, Nagashima, Fumio, Moriwaki, Toshikazu, Esaki, Taito, Sato, Takeo, Itabashi, Michio, Oki, Eiji, Sasaki, Toru, Sunaga, Yoshinori, Ziti‐Ljajic, Samira, Brillac, Claire, Yoshino, Takayuki
Published in Cancer science (01.03.2019)
Published in Cancer science (01.03.2019)
Get full text
Journal Article
Exploration of potential prognostic biomarkers in aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancer
Hamaguchi, Tetsuya, Denda, Tadamichi, Kudo, Toshihiro, Sugimoto, Naotoshi, Ura, Takashi, Yamazaki, Kentaro, Fujii, Hirofumi, Kajiwara, Takeshi, Nakajima, Takako Eguchi, Takahashi, Shin, Otsu, Satoshi, Komatsu, Yoshito, Nagashima, Fumio, Moriwaki, Toshikazu, Esaki, Taito, Sato, Takeo, Itabashi, Michio, Oki, Eiji, Sasaki, Toru, Chiron, Marielle, Yoshino, Takayuki
Published in Cancer science (01.11.2019)
Published in Cancer science (01.11.2019)
Get full text
Journal Article
Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum
Ito, Takahiko, Takashima, Atsuo, Yamazaki, Kentaro, Yukami, Hiroki, Uetake, Hiroyuki, Tsuda, Masahiro, Suto, Takeshi, Moriwaki, Toshikazu, Sugimoto, Naotoshi, Ojima, Hitoshi, Takii, Yasumasa, Yasui, Hisateru, Esaki, Taito, Tsuji, Akihito, Goto, Masahiro, Saruta, Masayuki, Otsu, Satoshi, Shinozaki, Katsunori, Fujiwara, Toshiyoshi, Tamura, Takao, Baba, Eishi, Shiozawa, Manabu, Denda, Tadamichi, Ueno, Hideki, Nagashima, Kengo, Shimada, Yasuhiro
Published in International journal of clinical oncology (01.09.2022)
Published in International journal of clinical oncology (01.09.2022)
Get full text
Journal Article
Randomized, Phase II study of pemetrexed plus bevacizumab versus pemetrexed alone after treatment with cisplatin, pemetrexed, and bevacizumab in advanced non‐squamous, non‐small cell lung cancer: TORG (thoracic oncology research group) 1321
Kasai, Takashi, Mori, Kiyoshi, Nakamura, Yoichi, Seki, Nobuhiko, Ichikawa, Yasuko, Saito, Haruhiro, Kondo, Tetsuro, Nishikawa, Kazuo, Otsu, Satoshi, Bessho, Akihiro, Tanaka, Hiroshi, Yamaguchi, Hiroyuki, Kaburagi, Takayuki, Imai, Hisao, Mori, Keita, Ohtake, Junya, Okamoto, Hiroaki
Published in Cancer medicine (Malden, MA) (01.07.2023)
Published in Cancer medicine (Malden, MA) (01.07.2023)
Get full text
Journal Article
Correction to: A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study
Otsuka, Taiga, Shirakawa, Tsuyoshi, Shimokawa, Mototsugu, Koga, Futa, Kawaguchi, Yasunori, Ueda, Yujiro, Nakazawa, Junichi, Komori, Azusa, Otsu, Satoshi, Arima, Shiho, Fukahori, Masaru, Okabe, Yoshinobu, Makiyama, Akitaka, Taguchi, Hiroki, Honda, Takuya, Shibuki, Taro, Nio, Kenta, Ide, Yasushi, Mizuta, Toshihiko, Mitsugi, Kenji, Ureshino, Norio
Published in International journal of clinical oncology (01.05.2021)
Published in International journal of clinical oncology (01.05.2021)
Get full text
Journal Article
First-line chemotherapy with S-1 alone or S-1 plus cisplatin for elderly patients with advanced gastric cancer: a multicenter propensity score matched study
Makiyama, Akitaka, Kunieda, Kenji, Noguchi, Masaaki, Kajiwara, Takeshi, Tamura, Takao, Takeda, Koji, Sugiyama, Junko, Minashi, Keiko, Moriwaki, Toshikazu, Sugimoto, Naotoshi, Nagase, Michitaka, Negoro, Yuji, Tsuda, Takashi, Shimodaira, Hideki, Okano, Naohiro, Tsuji, Akihito, Sakai, Daisuke, Yanagihara, Kazuhiro, Ueda, Shinya, Tamura, Shingo, Otsu, Satoshi, Honda, Takuya, Matsushita, Yuzo, Okuno, Tatsuya, Kashiwada, Tomomi, Nozaki, Akira, Ebi, Masahide, Okuda, Hiroyuki, Shimokawa, Mototsugu, Hironaka, Shuichi, Hyodo, Ichinosuke, Baba, Eishi, Boku, Narikazu, Muro, Kei, Esaki, Taito
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.09.2018)
Published in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (01.09.2018)
Get full text
Journal Article
Extramedullary Plasmacytoma as an Uncommon Cause of Gastrorrhagia
Morinaga, Ryotaro, Otsu, Satoshi, Kashima, Kenji, Watanabe, Koichiro
Published in Internal Medicine (01.01.2010)
Published in Internal Medicine (01.01.2010)
Get full text
Journal Article
Neurological Toxicity in Metastatic Colorectal Cancer Patients Treated with Modified FOLFOX6 Plus Bevacizumab
Otsu, Satoshi, Hirashima, Yoshinori, Nishikawa, Kazuo, Sakashita, Hiroyuki, Morinaga, Ryotaro, Watanabe, Koichiro, Shirao, Kuniaki
Published in Japanese Clinical Medicine (01.01.2014)
Published in Japanese Clinical Medicine (01.01.2014)
Get full text
Journal Article
Transfer of Antigen-Pulsed Dendritic Cells Induces Specific T-Cell Proliferation and a Therapeutic Effect against Long-Term Helicobacter pylori Infection in Mice
Otsu, Satoshi, Gotoh, Kazuyo, Yamashiro, Tetsu, Yamagata, Junpei, Shin, Kouichirou, Fujioka, Toshio, Nishizono, Akira
Published in Infection and Immunity (01.02.2006)
Published in Infection and Immunity (01.02.2006)
Get full text
Journal Article